CLINICAL_TRIALS
trial_result
· 2020-03-24
Clinical Trial Update: STP206 for the Prevention of Necrotizing Enterocolitis (NEC) [Phase 1]
Summary
Phase 1 trial update for STP206 in preventing necrotizing enterocolitis (NEC) has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Leadiant Biosciences, Inc. | Conditions: Necrotizing Enterocolitis | Phase 1 | Status: COMPLETED | Results posted: 2020-03-24